you are here:

Zenlabs Ethica Ltd.

BSE Live

Jan 19, 16:00
39.00 -1.40 (-3.47%)
Volume
No Data Available
12,021
  • Prev. Close

    40.40

  • Open Price

    40.10

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Dec 27, 11:22
NT* 0.00 (0.00%)
Volume
No Data Available
0
  • Prev. Close

    -

  • Open Price

    -

  • Bid Price (Qty.)

    - (0)

  • Offer Price (Qty.)

    - (0)

Zenlabs Ethica is not listed on NSE

ANNOUNCEMENTS ON Zenlabs Ethica

  • Dec 01, 2021 15:57 Source: BSE

    Zenlabs Ethica - Disclosures under Reg. 10(7) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(i)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Preet Remedies Ltd

  • Nov 23, 2021 18:36 Source: BSE

    Zenlabs Ethica - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Preet Remedies Ltd

  • Nov 23, 2021 18:34 Source: BSE

    Zenlabs Ethica - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Preet Remedies Ltd

  • Nov 03, 2021 14:19 Source: BSE

    Zenlabs Ethica - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Preet Remedies Ltd

  • Nov 02, 2021 11:22 Source: BSE

    Zenlabs Ethica - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    In pursuance to Regulations 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform you that the Company has received the intimation letter from the Registrar and Share Transfer Agent pertaining to issue of duplicate share Certificate in lieu of the original to the shareholder consequent to loss of share certificate being reported by the shareholder. The company shall approve and proceed to issue duplicate share certificate upon satisfaction of all the necessary documents required for processing. This is for the information of the exchange and members.

  • Nov 01, 2021 13:05 Source: BSE

    Zenlabs Ethica - Announcement under Regulation 30 (LODR)-Newspaper Publication

    Pursuant to Regulation 47 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we have pleasure to furnish herewith financial results for the quarter and half year ended on September 30, 2021, published in Financial Express - English and Dainik Tribune - Hindi, Chandigarh editions on Sunday, 31st October, 2021. The said results have also been uploaded on the website of the Company i.e. www.zenlabsethica.com.

  • Oct 30, 2021 15:14 Source: BSE

    Zenlabs Ethica - Approval Of Un-Audited Financial Results Of The Company For The Quarter Ended 30Th September, 2021.

    Pursuant to Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, we wish to inform you that the Board of Directors of the Company at their meeting held today on Saturday the 30th day of October, 2021 at 2:00 p.m. at the registered office of the company at Plot No. 194-195, 3rd Floor, Industrial Area, Phase-II, Chandigarh-160002 have considered and approved the un-audited financial results for the quarter and half year ended on September 30, 2021 as per Regulation 33 of SEBI (LODR), 2015. In this regard, we are enclosing herewith: 1. Un-audited Financial Results of the company for the quarter and half year ended on September 30, 2021 ; 2. Limited Review Report for the period ended on 30th September, 2021. You are requested to kindly take the same on record. Please also note that the company has made necessary arrangement for the publication of Un-audited Financial results as per the requirement of the SEBI (LODR) Regulations, 2015.

  • Oct 30, 2021 15:08 Source: BSE

    Zenlabs Ethica - Board Meeting Outcome for Outcome Of The Board Meeting Held On 30Th October, 2021 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.

    With reference to the above captioned subject, we wish to inform that the Board of Directors of the Company at their meeting held today on Saturday the 30th day of October, 2021 at 2:00 p.m. at the Registered Office of the company at Plot No. 194-195, 3rd Floor, Industrial Area, Phase-II, Ram Darbar, Chandigarh, 160002 have considered and approved the following: 1. The Un-audited financial results for the quarter and half year ended on September 30, 2021 as per Regulation 33 of SEBI (LODR), 2015; 2. Limited Review Report for the period ended on 30th September, 2021. The Board meeting commenced at 2:00 p.m. concluded at 3:00 p.m. You are requested to kindly take the same on record.

  • Oct 23, 2021 18:43 Source: BSE

    Zenlabs Ethica - Board Meeting Intimation for Notice Of Board Meeting As Per Regulation 29 Of SEBI (LODR) Regulations, 2015.

    Zenlabs Ethica Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015, we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday the 30th October, 2021 at the registered office of the Company at Plot No. 194-195, 3rd Floor, Industrial Area, Phase-II, Ram Darbar, Chandigarh, inter alia, to consider and approve the Un-audited Financial Results for the quarter and half year ended 30th September, 2021. You are requested to take the same on record.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Oct 30, 2021
Remark : Quarterly Results